Phase 3 Influenza, Human Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study of GP681 Tablets Compared With Placebo in Patients With Influenza at High Risk of Influenza Complications
Influenza, Human
Jiangxi Qingfeng Pharmaceutical Co. Ltd.328 enrolled1 locationNCT06573008
Terminated
Phase 3Phase 4
Reactogenicity Study of Afluria Quad/Afluria Quad Junior in Children
Influenza, Humans
Seqirus1,800 enrolled1 locationACTRN12619000792123